J&J | JNJ - Selling And Administration Expenses


J&J reported $6.42B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Abbott USD 3.6B 330M Jun/2026
Amgen USD 1.72B 134M Jun/2026
AstraZeneca USD 5.8B 735M Jun/2026
Baxter International USD 735M 7M Jun/2026
Bayer EUR 3.96B 267M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Biogen USD 709.7M 155.4M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
CONMED USD 145.55M 3.85M Jun/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Eli Lilly USD 3.43B 496M Jun/2026
Gilead Sciences USD 1.52B 70M Jun/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Globus Medical USD 286.82M 10.95M Jun/2026
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
J&J USD 6.42B 381M Jun/2026
Medtronic 3.2B 141M Jun/2026
Merck USD 2.89B 219M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Novartis USD 3.24B 101M Jun/2026
Pfizer USD 3.41B 496M Jun/2026
Regeneron Pharmaceuticals USD 662.1M 14.4M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teva Pharmaceutical Industries USD 1.03B 34M Jun/2026
Vertex Pharmaceuticals USD 582.2M 88.5M Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026
Zoetis USD 592M 4M Jun/2026